Apollo Medical Holdings (OTC: AMEH) is a leading integrated
healthcare company providing solutions to hospitals, health plans, physicians
and other health providers that enable cost-effective, quality healthcare. The
company utilizes integrated care solutions in order to identify and manage
patients who are at-risk for chronic conditions. By coordinating care for these
patients across multiple facilities, ApolloMed helps them reduce hospital
admissions and avoid unnecessary emergency room visits, providing the means for
reduced overall medical costs without sacrificing on quality of care.
Earlier this month, ApolloMed announced that its network of
physicians had surpassed 1,000 providers. Through this network, the company is
able to provide leading health management services to more than 40,000 of its
own patients, as well as over 75,000 additional patients for its clients. The
company’s network of dedicated hospitalists, nursing home physicians, clinic
physicians, hospice care group and home health agency allow ApolloMed to
provide care for some of the most complex and highest cost patients in the
United States healthcare system.
Moving forward, ApolloMed is in a strong position to
capitalize on the evolving landscape of the medical industry, particularly as
it relates to value-based payments. In January, the U.S. Department of Health
and Human Services (HHS) announced substantial changes to the way in which
Medicare payments will be processed in the future. HHS set a goal of tying 30
percent of fee-for-service Medicare payments to quality or value through
alternative payment models by the end of 2016. By the end of 2018, this change
is expected to affect at least 50 percent of all Medicare payments. This
announcement marked the first time in the history of the Medicare program that
explicit goals for value-based payments have been set.
“Over the past three years, we have built a growing, robust
network of physicians and an outcome-centric population health management
platform that is at the forefront of the movement to value-based care,” Dr.
Warren Hosseinion, chief executive officer of ApolloMed, stated in a news
release. “We believe ApolloMed is well positioned to benefit from these
transformative changes and sizable market growth over the next decade.”
For prospective shareholders, ApolloMed represents an
opportunity to invest in an established player in the value-based medical
market. With the recently announced shift in Medicare payment processing, the
company’s developed and expanding network of medical group and accountable care
organization physicians could provide a platform for increased revenues and, as
a result, sustainable shareholder returns in the years to come.
For more information, visit www.apollomed.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment